Status: Recruiting
First-In-Human Clinical Study for Treatment of Severe Mitral Valve INsufficiency With Epygon™ TRanscatheter Mitral VAlve System
The EPYGON VALVE is an innovative mitral valve, intended for valve replacement of a native mitral valve through a minimally invasive implant procedure by means of a dedicated implant device. The EPYGON VALVE is a bio prosthesis, composed by a functional assembly of bovine pericardium on a NiTinol stent. The purpose of this trial is to assess the safety and feasibility of the Epygon™ Transcatheter mitral valve and the transapical delivery system, in adult patients with severe, symptomatic mitral regurgitation.
Participants needed: 40
Trial details
Age: 60+Biological sex: AllType: InterventionalSponsor: EpygonUpdated: Aug 7, 2023Locations: 10
Eligibility criteria
Patients of age ≥ 60 years. [+7]
Patients involved in other clinical assessments for drugs or devices that could... [+25]